Clinical trial
Study on the Treatment of Hairy Cell Leukaemia Variant and Relapsing Hairy Cell Leukaemia
NCT02157181 is registered in ClinicalTrials.gov with Jurgen Barth as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Study on the Treatment of Hairy Cell Leukaemia Variant and Relapsing Hairy Cell Leukaemia
- Lead sponsor
- Jurgen Barth
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- June 30, 2004
- Completion date
- January 31, 2013
- Enrollment
- 89 (actual)
- Sites
- 47
Conditions
As the registry lists them; a condition with its own page is linked.
hairy cell leukemia (hcl)